Filter Results:
(4,962)
Show Results For
- All HBS Web
(4,962)
- People (16)
- News (1,906)
- Research (2,472)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,885)
Show Results For
- All HBS Web
(4,962)
- People (16)
- News (1,906)
- Research (2,472)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,885)
- October 2010 (Revised November 2010)
- Background Note
Plavix: Drugs in the Age of Personalized Medicine
By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
PIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon, and recently new data had been discovered that indicated that a small subset of the population would be at risk for stroke, heart attack, or even... View Details
Keywords: Health Care and Treatment; Product Positioning; Business and Government Relations; Genetics; Competitive Strategy; Pharmaceutical Industry
Hamermesh, Richard G., Mara G. Aspinall, and Rachel Gordon. "Plavix: Drugs in the Age of Personalized Medicine." Harvard Business School Background Note 811-001, October 2010. (Revised November 2010.)
- Web
Leadership - Faculty & Research
Pressure (A)." Harvard Business School Case 225-082, June 2025. Dell Med: Transforming Care Delivery & Payment By: Robert S. Kaplan , David N. Bernstein and Mary L. Witkowski May 2025 | Case | Faculty Research View Details
- 09 Jun 2015
- First Look
First Look: June 9, 2015
allowed by health authorities. Yet caries remained a significant threat to public health in many countries, both developing and developed. As Suzan Harrison, Colgate's president of Oral Care, prepared to... View Details
Keywords: Sean Silverthorne
- 06 Mar 2007
- First Look
First Look: March 6, 2007
Self-Policing in the Shadow of the Regulator Authors:Jodi L. Short and Michael W. Toffel Abstract As part of a recent trend toward more cooperative relations between regulators and industry, novel government... View Details
Keywords: Martha Lagace
- November 2017
- Article
A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies
By: S. Balsari, P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough and T. Khanna
Cardiovascular disease is the leading cause of mortality from noncommunicable diseases (NCD) in India. The government’s National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke seeks to increase capacity building, screening,... View Details
Balsari, S., P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough, and T. Khanna. "A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies." Journal of Human Hypertension 31, no. 11 (November 2017): 750–753.
Debora L. Spar
Debora Spar is the Jaime and Josefina Chua Tiampo Professor of Business Administration at Harvard Business School and Senior Associate Dean for Business and Global Society. Her current research focuses on issues of gender and technology, and the interplay between... View Details
Keywords: health care; health care; health care; health care; health care; health care; health care; health care; health care; health care
- Web
Events & Presentations - Institute For Strategy And Competitiveness
competitiveness, strategies for business, creating shared value, and other topics. Recent & Upcoming Events November 16-18, 2022 November 2022 Strategy for Health Care Delivery HBS Campus, Boston, MA... View Details
- 24 Jul 2007
- First Look
First Look: July 24, 2007
to use its limited resources focusing on Home Depot or find a new target to forward their cause. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=407097 Apollo Hospitals—First-World Health View Details
Keywords: Martha Lagace
- Web
Publications - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care View Details
Rosabeth M. Kanter
Rosabeth Moss Kanter holds the Ernest L. Arbuckle Professorship at Harvard Business School, specializing in strategy, innovation, and leadership for change. Her strategic and practical insights guide leaders worldwide through teaching, writing, and direct... View Details
Keywords: health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care
- Web
Employment Data Trends
Employment Data Trends Employment Data Trends Trends Career Data Internship Data Trends by Industry 2020 2021 2022 2023 2024 Consulting 24% 23% 26% 25% 18% Consumer Products 3% 3% 3% 4% 3% Entertainment / Media 2% 3% 3% 1% 3% Health View Details
- Web
Hidden Workers, Untapped Talent - Managing the Future of Work
Report Hidden Workers: Part-Time Potential By: Joseph B. Fuller, Manjari Raman, & Francis Hintermann 13 MAR 2023 Part-time workers constitute a substantial segment of America’s hidden workers. They would like to work more but circumstances—e.g., caregiving... View Details
- Web
Aligning Reimbursement with Value - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care View Details
- September 2017 (Revised July 2023)
- Case
Adaptive Platform Trials: The Clinical Trial of the Future?
By: Ariel D. Stern and Sarah Mehta
In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer.... View Details
Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; Health; Health Care and Treatment; Health Testing and Trials; Business Strategy; Innovation Strategy; Health Industry; United States
Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Case 618-025, September 2017. (Revised July 2023.)
- May 2024 (Revised February 2025)
- Case
Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell
By: Jon M. Jachimowicz and Alexis Lefort
Brooke Boyarsky Pratt (HBS ’13) enjoyed considerable success in her early career, quickly climbing the ranks to associate partner at McKinsey, and later becoming an executive vice president at Berkadia, a Berkshire Hathaway portfolio company. Throughout these years,... View Details
Keywords: Passion; Career; Career Planning; Purpose; Personal Development and Career; Mission and Purpose; Identity; Business Startups; Health Care and Treatment; Health Disorders; Growth and Development Strategy; Market Entry and Exit; Health Industry; United States
Jachimowicz, Jon M., and Alexis Lefort. "Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell." Harvard Business School Case 424-040, May 2024. (Revised February 2025.)
- 05 Jun 2007
- First Look
First Look: June 5, 2007
Case 707-559 Describes the joint efforts of the German health plan KKH and Essen University Hospital to develop an integrated practice unit (IPU), and the West German Headache Center's efforts to improve the quality of migraine care.... View Details
Keywords: Martha Lagace
- 22 May 2024
- HBS Case
Banned or Not, TikTok Is a Force Companies Can’t Afford to Ignore
algorithm triangulate what users care about. It chooses for you. It is constantly making and validating hypotheses about you. It is learning. “What they've been able to do is somehow break through this notion of ‘How do I know somebody?... View Details
- October 1982 (Revised May 1992)
- Case
Johnson & Johnson: The Tylenol Tragedy
In October 1982, Johnson & Johnson was confronted with a major crisis when seven deaths were attributed to poisoned Tylenol. The case reviews the facts as known a week after the incident occurred, and raises a wide range of questions regarding consumer behavior,... View Details
Keywords: Consumer Behavior; Corporate Social Responsibility and Impact; Competitive Strategy; Crisis Management; Health Care and Treatment; Pharmaceutical Industry
Greyser, Stephen A. "Johnson & Johnson: The Tylenol Tragedy." Harvard Business School Case 583-043, October 1982. (Revised May 1992.)
- 18 Jul 2023
- News
The First Five Years: Brooke Biederman (MBA 2019)
What inspired you to launch Forby Entertainment Partners? I started working on film and TV shoots in New York City during college. My first boss, an executive producer, recommended Edward Jay Epstein’s book, The Hollywood Economist: The Hidden Financial Reality Behind... View Details
Keywords: Robert Bochnak
- 13 Jul 2023
- News
The Network Effect
Karan Mathur (left) and Dina Model (Illustration by Gisela Goppel) Karan Mathur (left) and Dina Model (Illustration by Gisela Goppel) When Dina Model and Karan Mathur (both MBA 2015) met through mutual friends during their first year at HBS, neither was envisioning a... View Details